Literature DB >> 19049338

Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications.

Masahiro Yamamoto1, Toru Yamaguchi, Mika Yamauchi, Hiroshi Kaji, Toshitsugu Sugimoto.   

Abstract

Although patients with type 2 diabetes (T2DM) have an increased risk of hip fracture, risk of vertebral fracture (VF) and its association with BMD are still unclear. We examined Japanese T2DM patients (161 men >50 yr and 137 postmenopausal women) and non-DM controls (76 and 622, respectively) by lateral spine radiography and DXA at the lumbar spine (L), femoral neck (FN), and radius (R). Logistic regression analysis adjusted for age, body mass index, and L-BMD showed that the presence of T2DM was an independent risk factor for prevalent VFs in women (OR = 1.86, p = 0.019) and men (OR = 4.73, p < 0.001). BMD at any site, however, was not significantly associated with the presence of prevalent VFs in T2DM patients, in contrast to the significant association in controls (at least p = 0.010). Comparison of T2DM patients with and without VFs showed no significant differences in BMD values, bone markers, or diabetes status. Receiver operating characteristic analysis showed that the absolute L-, FN-, and R-BMD values for detecting prevalent VFs were higher in T2DM patients than controls, whereas their sensitivity and specificity were lower. T2DM patients may have an increased risk of VFs independent of BMD or diabetic complication status, suggesting that bone quality may define bone fragility in T2DM.

Entities:  

Mesh:

Year:  2009        PMID: 19049338     DOI: 10.1359/jbmr.081207

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  93 in total

1.  Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus.

Authors:  I Kanazawa; K Tanaka; N Ogawa; M Yamauchi; T Yamaguchi; T Sugimoto
Journal:  Osteoporos Int       Date:  2012-06-06       Impact factor: 4.507

2.  Serum insulin-like growth factor-I is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus.

Authors:  I Kanazawa; T Yamaguchi; T Sugimoto
Journal:  Osteoporos Int       Date:  2010-06-08       Impact factor: 4.507

Review 3.  Bone health and type 2 diabetes mellitus: a systematic review.

Authors:  Erin Gorman; Anna M Chudyk; Kenneth M Madden; Maureen C Ashe
Journal:  Physiother Can       Date:  2011-01-20       Impact factor: 1.037

Review 4.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

5.  Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus.

Authors:  Ippei Kanazawa; Toru Yamaguchi; Masahiro Yamamoto; Toshitsugu Sugimoto
Journal:  J Bone Miner Metab       Date:  2010-02-23       Impact factor: 2.626

6.  High glucose promotes mineralization via bone morphogenetic protein 4-Smad signals in early stage of osteoblast differentiation.

Authors:  Ayumu Takeno; Ippei Kanazawa; Ken-Ichiro Tanaka; Masakazu Notsu; Keizo Kanasaki; Takamasa Oono; Yoshihiro Ogawa; Toshitsugu Sugimoto
Journal:  Diabetol Int       Date:  2020-08-30

Review 7.  A review of rodent models of type 2 diabetic skeletal fragility.

Authors:  Roberto J Fajardo; Lamya Karim; Virginia I Calley; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

8.  Vertebral Fracture Risk in Diabetic Elderly Men: The MrOS Study.

Authors:  Nicola Napoli; Ann V Schwartz; Anne L Schafer; Eric Vittinghoff; Peggy M Cawthon; Neeta Parimi; Eric Orwoll; Elsa S Strotmeyer; Andrew R Hoffman; Elizabeth Barrett-Connor; Dennis M Black
Journal:  J Bone Miner Res       Date:  2017-12-27       Impact factor: 6.741

9.  Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women.

Authors:  S Tanaka; T Kuroda; M Saito; M Shiraki
Journal:  Osteoporos Int       Date:  2012-11-15       Impact factor: 4.507

10.  Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength.

Authors:  S V Lim; M Marenzana; M Hopkinson; E O List; J J Kopchick; M Pereira; B Javaheri; J P Roux; P Chavassieux; M Korbonits; C Chenu
Journal:  Endocrinology       Date:  2015-02-03       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.